Simethicone as Part of ERAS in Bariatric Surgery Patients
Eligible age
18–89 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery. The purpose of this research is to gather information on the safety and effectiveness of simethicone. Simethicone (more commonly known as Gas Relief or Gas-X) relieves pressure, bloating, and fullness commonly referred to as gas. It is FDA approved. The use of this medication in this research study is consistent with labeling indications.
Sponsor: Madigan Army Medical Center
You may qualify if…
- ✓ Foregut procedures
You may not qualify if…
- ✕ Non-foregut procedures
- ✕ Allergy to simethicone
- ✕ Pregnancy or breastfeeding
- ✕ Minors under 18 years of age
Where it's recruiting
Tacoma
Source: ClinicalTrials.gov · NCT06812832 · last updated 2025-06-15